We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Enhancing the Data Screening Process


Enhancing the Data Screening Process

Who's speaking at this Webinar?

Dr. Dana Kawahara
Research Scientist, Albany Molecular Research Inc. (AMRI)
Dr.Daniel Weaver
Senior Product Manager and Solutions Architect for Research, PerkinElmer, Inc.

Despite years of effort in the pharmaceutical R&D informatics space, many organizations still process their screening data through Excel spreadsheets or home-grown data systems.These organizations likely own TIBCO® Spotfire® which has robust data analysis functionality, but, for various reasons, they do not use it for screening data.

Join our customer, Albany Molecular Research Inc and PerkinElmer to learn how you can overcome challenges with:

-Generating high quality leads fast enough
-Enormous amounts of data generated in different assay formats
-Administrative tasks that take time away from drug discovery

In this session, AMRI, a global contract research and manufacturing organization, will share:
- How they normalized their screening process
- How that impacted their operations
- The role PerkinElmer played in this process
- Recommendations for similar efforts.


Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Drug Discovery Informatics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free